Table 1 Variables analyzed to create the typology
From: Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models
Feature studied | Variable studied per vaccine |
|---|---|
R&D investments | R&D funder’s country of origin |
Investment size | |
Regulatory approvals | Number of regulatory approvals |
Percentage of regulatory approvals by country’s income level | |
Time to regulatory approval since the first approval globally | |
Manufacturing agreements | Number of manufacturing agreements |
Percentage of manufacturing agreements by country’s income level | |
Purchase agreements | Number of doses committed |
Percentage of doses sold by purchaser’s income level | |
Timeline of agreements since each vaccine’s first purchase | |
Vaccine deliveries | Number of doses delivered |
Percentage of deliveries by recipient’s income level | |
Timeline of deliveries by recipient’s income level |